Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07165600 · ClinicalTrials.gov registry record · NA

Yoga to Improve Disparities in Cancer Survivorship

A NA study of Cancer and Survivorship, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07165600: Recruiting NA study of Cancer and Survivorship, sponsored by University of California, San Francisco.

NCT07165600 is a NA study of Cancer and Survivorship that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 50 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07165600, a NA study of Cancer and Survivorship, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This clinical trial tests the impact of a racially concordant trainer led yoga program on quality of life and symptom burden in Black and/or African American cancer survivors. Black individuals in the United States are more affected by cancer, despite modern advances. Cancer treatments can impact physical and mental health and overall quality of life and Black individuals report worse physical function and quality of life and less access to culturally appropriate support services. Yoga has been shown to have a positive impact on cancer and cancer treatment related symptoms and quality of life, however, a one size fits all approach has not been shown to be effective in diverse populations. A trainer that shares the same racial or ethnic background as the participant (racially concordant) may have a positive impact on communication, trust, and may improve accessibility and participation. Participating in a yoga program led by a racially concordant trainer may improve quality of life and symptom burden in Black and/or African American cancer survivors.

Primary Outcome

The completion rate is defined as the proportion of enrolled individuals who attend at least 2 yoga sessions.

Conditions Studied

Interventions

  • OTHER Yoga

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-09-24
Est. Completion 2026-10-31
Phase NA

What NCT07165600 shows while recruiting

NCT07165600 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Yoga is the first listed.

NCT07165600 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT07165600 about?

NCT07165600 is a clinical study titled "Yoga to Improve Disparities in Cancer Survivorship". This clinical trial tests the impact of a racially concordant trainer led yoga program on quality of life and symptom burden in Black and/or African American cancer survivors. Black individuals in the United States are more affected by cancer, despite modern advances. Cancer treatments can impact ph...

What is the current status of trial NCT07165600?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-09-24. Estimated completion is 2026-10-31.

What conditions does trial NCT07165600 study?

This clinical trial studies the following conditions: Cancer, Survivorship.

What interventions are being tested in trial NCT07165600?

The interventions under investigation include: Yoga (OTHER).

Who is sponsoring clinical trial NCT07165600?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07165600 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07165600's enrollment target sits among peer trials

50 422nd of 615 higher than 179 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07165600, the US trial registry maintained by the National Library of Medicine. NCT07165600 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.